Onex Canada Asset Management’s AstraZeneca AZN Stock Holding History

Onex Canada Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,287	Closed	-$1.02M	–	74
2025 Q2	$1.02M	Sell	7,287 -6,920	-49%	-$970K	0.12%	95
2025 Q1	$2.09M	Buy	+14,207	New	+$2.06M	0.27%	85
2024 Q3	–	Sell	-16,420	Closed	-$5.13M	–	112
2024 Q2	$5.13M	Buy	16,420 +1,500	+10%	+$226K	0.58%	48
2024 Q1	$4.02M	Buy	14,920 +4,750	+47%	+$629K	0.4%	80
2023 Q4	$2.75M	Sell	10,170 -4,225	-29%	-$549K	0.27%	103
2023 Q3	$3.9M	Sell	14,395 -5,010	-26%	-$684K	0.3%	93
2023 Q2	$5.56M	Buy	19,405 +12,505	+181%	+$1.84M	0.34%	85
2023 Q1	$1.91M	Buy	+6,900	New	+$928K	0.1%	122

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Onex Canada Asset Management's AZN Position: Q3 2025 in Review

Onex Canada Asset Management sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 7,287 shares — an estimated $1.02M sold.

Onex Canada Asset Management first reported a position in AZN in Q1 2023 and held it in 8 quarters. The position peaked at $5.56M in Q2 2023. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Onex Canada Asset Management reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
Onex Canada Asset Management sold 7,287 AstraZeneca shares in Q3 2025, an estimated $1.02M.
Onex Canada Asset Management first reported a position in AstraZeneca in Q1 2023 and held it in 8 quarters.
Onex Canada Asset Management's AstraZeneca position peaked at $5.56M in Q2 2023.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Onex Canada Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.